Posted on over 1 year ago by Laurentina Kennedy
West Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for West’s advanced manufacturing network, and the launch of a new product line—Westar® Select. Customers and senior-level Irish government officials joined West at a ribbon-cutting ceremony to celebrate the facility’s opening and to recognise West’s ongoing commitment to improving patient lives through their products and services. “West is very pleased to celebrate the official opening of our state-of-the-art facility in Waterford, as well as the launch of Westar Select, both of which are the culmination of efforts by many to support our Company’s commitment to meeting the dynamic needs of our pharmaceutical and biotech partners,” said Eric Green, President and CEO, West. “Our investment in Waterford, in addition to our previously announced investments in Kinston, North Carolina, United States, Jurong, Singapore, and Dublin, Ireland, enable West to provide the highest levels of quality across the products and services we provide for the global customer base we serve.”
The new, 20,500 square meter facility, situated on a 44-acre campus, will produce West’s proprietary elastomeric laminate sheeting, which is used to package insulin for use in pen injectors. Additionally, it will offer high-value finishing for components, including stoppers and plungers, produced at other West facilities around the world. These services, designed to mitigate the risk of potential contamination and compatibility issues with packaging components, include pharmaceutical washing (Westar® RS components), Envision® verification, steam sterilization (Westar® RU components) and flexible packaging offerings.